Corcept Therapeutics
CORT
#2078
Rank
S$11.75 B
Marketcap
S$111.58
Share price
1.71%
Change (1 day)
40.29%
Change (1 year)

Corcept Therapeutics (CORT) - Net assets

Net assets on the balance sheet as of September 2025 : S$0.81 Billion

According to Corcept Therapeutics 's latest financial reports the company has S$0.81 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Corcept Therapeutics - Net assets on balance sheet (from 2003 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$0.92 B38.04%
2023-12-31$S$0.66 B-0.53%
2022-12-31$S$0.67 B32.42%
2021-12-31$S$0.50 B-26.62%
2020-12-31$S$0.69 B38.35%
2019-12-31$S$0.50 B32.77%
2018-12-31$S$0.37 B47.56%
2017-12-31$S$0.25 B326.5%
2016-12-31$S$59.88 M128.88%
2015-12-31$S$26.16 M-684.49%
2014-12-31$-S$4.48 Million-116.81%
2013-12-31$S$26.62 M-64.75%
2012-12-31$S$75.54 M67.6%
2011-12-31$S$45.07 M64.73%
2010-12-31$S$27.36 M-11.77%
2009-12-31$S$31.01 M28.27%
2008-12-31$S$24.17 M14.04%
2007-12-31$S$21.2 M117.4%
2006-12-31$S$9.75 M-77.97%
2005-12-31$S$44.27 M-40.93%
2004-12-31$S$74.95 M-240.18%
2003-12-31$-S$53.48 Million40.46%
2002-12-31$-S$38.07 Million-191.91%
2001-12-31$S$41.42 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Johnson & Johnson
JNJ
S$102.73 B 12,445.77%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$24.10 B 2,843.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Novartis
NVS
S$57.99 B 6,982.11%๐Ÿ‡จ๐Ÿ‡ญ Switzerland
Eli Lilly
LLY
S$30.90 B 3,674.45%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$120.64 B 14,632.66%๐Ÿ‡บ๐Ÿ‡ธ USA
Merck
MRK
S$67.26 B 8,114.41%๐Ÿ‡บ๐Ÿ‡ธ USA
Esperion Therapeutics
ESPR
-S$0.59 Billion-171.43%๐Ÿ‡บ๐Ÿ‡ธ USA
MannKind Corp
MNKD
-S$57.74 Million-107.05%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$7.84 B 858.49%๐Ÿ‡บ๐Ÿ‡ธ USA